Stopping The Spread of Prostate Cancer
Researchers from Massachusetts General Harvard, Dana Farber Cancer Institute and Brigham and Women’s Hospital recently revealed that long-term use of aspirin is associated with lower risk of dying from various types of cancers, including lung and prostate cancer. Both cancers are the leading killers of men. The findings were presented at the April 2017 meeting of the American Association for Cancer Research.
Apparently aspirin not only reduces the risk of developing cancer, but may also play a strong role in reducing death from cancer,” according to Yin Cao, the lead author of the study and an instructor Massachusetts General Hospital and Harvard Medical School.
Reductions in overall mortality risks from cancer were noted at dosages ranging from half a standard aspirin tablet per week to seven tablets weekly.
Women who took aspirin were also at a 11 percent lower risk of dying from breast cancer. Men who took aspirin had a 23 percent lower risk of dying from prostate cancer, the study found.
Although aspirin has been shown to reduce the risk of heart disease and strokes, daily aspirin use is known to increase the likelihood of gastrointestinal bleeding.